Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at so that we can update the bibliography.


 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website



Export 11 results:
Author Title [ Type(Desc)] Year
Filters: Author is Poole, C. D.  [Clear All Filters]
Journal Article
C. J. Currie, Berni, E., Jenkins-Jones, S., Poole, C. D., Ouwens, M., Driessen, S., de Voogd, H., Butler, C. C., and Morgan, C. L., Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis, Bmj, vol. 349, p. g5493, 2014.
C. L. Morgan, Puelles, J., Poole, C. D., and Currie, C. J., The effect of withdrawal of rosiglitazone on treatment pathways, diabetes control and patient outcomes: a retrospective cohort study, J Diabetes Complications, vol. 28, pp. 360-4, 2014.
C. A. Bannister, Poole, C. D., Jenkins-Jones, S., Morgan, C. L., Elwyn, G., Spasic, I., and Currie, C. J., External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations, Diabetes Care, vol. 37, pp. 537-45, 2014.
S. H. Holden, Barnett, A. H., Peters, J. R., Jenkins-Jones, S., Poole, C. D., Morgan, C. L., and Currie, C. J., The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010, Diabetes Obes Metab, vol. 15, pp. 844-52, 2013.
C. J. Currie, Poole, C. D., Evans, M., Peters, J. R., and Morgan, C. L., Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes, J Clin Endocrinol Metab, vol. 98, pp. 668-77, 2013.
C. D. Poole, Halcox, J. P., Jenkins-Jones, S., Carr, E. S., Schifflers, M. G., Ray, K. K., and Currie, C. J., Omega-3 Fatty acids and mortality outcome in patients with and without type 2 diabetes after myocardial infarction: a retrospective, matched-cohort study, Clin Ther, vol. 35, pp. 40-51, 2013.
S. E. Holden, Jenkins-Jones, S., Poole, C. D., Morgan, C. L., Coghill, D., and Currie, C. J., The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010), Child Adolesc Psychiatry Ment Health, vol. 7, p. 34, 2013.
C. L. Morgan, Owens, D. R., Aubonnet, P., Carr, E. S., Jenkins-Jones, S., Poole, C. D., and Currie, C. J., Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study, BMJ Open, vol. 3, p. e004025, 2013.
C. J. Currie, Peters, J. R., Tynan, A., Evans, M., Heine, R. J., Bracco, O. L., Zagar, T., and Poole, C. D., Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study, Lancet, vol. 375, pp. 481-9, 2010.
C. L. Morgan, Jenkins-Jones, S., Evans, M., Barnett, A. H., Poole, C. D., and Currie, C. J., Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs, Diabetes Obes Metab, vol. 14, pp. 424-32, 2012.
C. L. Morgan, Poole, C. D., Evans, M., Barnett, A. H., Jenkins-Jones, S., and Currie, C. J., What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes, J Clin Endocrinol Metab, vol. 97, pp. 4605-12, 2012.
[Page last reviewed 6 April 2021]